Park Medi World Limited IPO

Apply 0
Avoid 0

Don't Miss It! Mark Your Calender Now:


Park Medi World Limited is the second largest private hospital chain in North India with 3,000 beds, operating 14 NABH-accredited multi-super specialty hospitals across four states, supported by 1,014 doctors and 2,142 nurses. Established from its first hospital in 2005, the Company has rapidly expanded through strategic greenfield projects and eight successful acquisitions—now contributing over 55% of its revenue and profitability—demonstrating strong execution and integration capabilities.

Extensive Hospital Network and Bed Capacity

The Company has expanded its bed capacity from 2,550 in FY23 to 3,250 as of September 30, 2025, and is undertaking major growth projects across Ambala, Panchkula, Rohtak, Gorakhpur, Kanpur, and Narela. These include new hospitals, capacity upgrades, and strategic acquisitions, which are expected to increase total bed capacity to 4,900 by March 31, 2028.

Strategic Approach and Operating Model

The Company adopts a cluster-based expansion strategy, allowing hospitals in nearby locations to share resources, improve efficiency, and benefit from economies of scale. This model enhances cost management and margins, while a diversified payor mix across cash, corporate, government, and insurance segments ensures stable and balanced revenues.

Clinical Infrastructure and Specialty Services

Park Medi World operates advanced clinical infrastructure comprising:

– 870 ICU beds
– 67 operating theatres
– Two comprehensive cancer units equipped with linear accelerators
– Oxygen generation plant at each hospital
– 24×7 trauma and emergency care with specialist coverage

The Company has also established Institutes of Minimal Access, Advanced Surgical Sciences and Robot-Assisted Surgery (iMARS) at Gurugram (Sector 47), Palam Vihar, and Mohali, offering robotic and minimally invasive surgeries for improved patient outcomes.

Objects of the Park Medi World Limited IPO:

Company proposes to utilise the Net Proceeds towards the following objects: 1. Repayment/ prepayment of certain borrowings of Company and Subsidiaries (₹380 cr) 2. Capital expenditure for development of new hospital by Subsidiary, Park Medicity in NCR (₹60.5 cr) 3. Capital expenditure for purchase of medical equipment by Company and Subsidiaries, Blue Heavens and Ratangiri (₹27.5 cr) 4. Unidentified inorganic acquisitions and general corporate purposes

Park Medi World Limited IPO Details:

Open Date: Dec 10 2025
Close Date: Dec 12 2025
Total Shares: 5,67,90,123
Face Value: ₹ 2 Per Equity Share
Issue Type: Book Building
Issue Size: 920 Cr.
Lot Size: 92 Shares
Issue Price: ₹ 154 - 162 Per Equity Share
Listing At: NSE,BSE
Listing Date: Dec 17 2025

Promoters And Management:

1. Dr. Ajit Gupta – Promoter, Chairman & Whole-Time Director. A qualified MBBS from the University of Delhi, he has been registered with the Medical Council of India since 1981 and has over 25 years of experience in the nursing home and hospital sector. Prior to joining the Company in 2011, he served at Safdarjung Hospital and later managed Park Hospital and Sunil Nursing Home. 2. Dr. Ankit Gupta – Promoter & Managing Director. An MBBS graduate from Bharati Vidyapeeth University, Pune, he has over 20 years of medical and hospital operations experience. Registered with the Delhi Medical Council since 2005, he previously headed operations at Park Hospital before joining the Company in 2011. He continues to drive medical strategy and operational efficiency. 3. Dr. Sanjay Sharma – Whole-Time Director & Chief Executive Officer. An MBBS from the University of Delhi, he has over 20 years of experience across clinical roles and senior management positions in leading hospitals. He joined the Park Group in 2014 and became CEO of the Company in 2024. His prior experience includes leadership roles at Fortis, SevenHills Healthcare, Alchemist Hospitals, and other renowned healthcare institutions.

Financials of Park Medi World Limited IPO:

Particulars 6M FY2025-26 6M FY2024-25 FY 2024-25 FY 2023-2024 FY 2022-2023
Revenue from Operations (Cr) 808.60 691.50 1393.50 1231.00 1244.50
EBITDA (Cr) 217.10 189.50 372.10 310.30 390.30
EBITDA Margins 26.85% 27.42% 26.71% 25.21% 3.11%
PAT (Cr) 139.1 112.8 213.2 152 228.1
PAT Margins 17.21% 16.33% 15.30% 12.35% 18.19%
ROCE 9.55% 9.63% 17.47% 16.07% 26.78%
D/E Ratio 0.58 0.62 0.61 0.73 0.79
OPerating Cash Flow 45.4 118.9 191.5 361.45 195
 

Comparison With Peers:

Companies Revenue (in cr) EBITDA Margins PAT Margins ROCE D/E Ratio MCap (in cr) P/E
Park medi World Ltd. 139.35 26.71% 15.30% 17.47% 0.61 6997.27 32.82
Apollo Hospitals Enterprise Limited 21794 14% 6.91% 16.60% 0.88 103409 62
Fortis Healthcare Limited 7783 20% 10.39% 12.00% 0.34 67342 66.8
Global Health Limited 3692 24% 13.02% 19.70% 0.25 31161 52.2
Jupiter Lifeline Hospitals Limited 1262 24% 15.37% 18.00% 0.28 9393 47
Krishna Institute of Medical Sciences Limited 3035 26% 13.67% 15.00% 1.4 27966 85.1
Max Healthcare Institute Limited 7028 26% 15.31% 14.90% 0.33 106032 75
Narayana Hrudalaya Limited 5483 24% 14.24% 20.80% 0.56 39582 46.5
Yatharth Hospital & Trauma Care Services Limited 860 26% 15.23% 14% 0.02 6576 43.1
Note : Forward P/E 25.15 is According to FY26 PAT

Registrar of Park Medi World Limited IPO:

  1. Kfin Technology Private Limited

Discussion on Park Medi World Limited IPO:

Leave a Reply